Genexine has ranked among the top searched stocks for 13 days in the past month.


As of 12:31 PM on the 3rd, Genexine is trading at 183,200 KRW, up 0.16% from the previous day. This represents a 55.25% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners are tentatively recorded as net buyers of 2,000 shares. Over the past five days, individual investors have net purchased 374,132 shares, while foreigners and institutions have net sold 53,520 shares and 146,320 shares, respectively.


On August 31, Genexine became a market issue with the news of "FDA approval for Kimria combination therapy clinical Phase 1b," which led to a price increase.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing